Auransa Presents New Preclinical Data on AU-409, a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing